Favorable Phase 1 Interim Results for Chikungunya Vaccine Candidate

There have been more than 1 million reported cases of in the Americas.   There are no approved treatments or vaccines for the mosquito-borne viral disease.   Valneva SE recently reported favorable phase 1 interim results for their vaccine candidate VLA1553.

Read more at Contagion…


By |2019-01-12T20:25:25+00:00January 12th, 2019|

Leave A Comment